COHU · XBRL financial data

Cohu financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (COHU's year ends in late December)

In millions of dollarsDec 30, 2023Mar 30, 2024Jun 29, 2024Sep 28, 2024Dec 28, 2024Mar 29, 2025Jun 28, 2025Sep 27, 2025Dec 27, 2025Mar 28, 2026Jun 27, 2026Sep 26, 2026
Research and development22*22212021*23232223*262526
Selling, general and administrative33*35323031*30303232*353433
Operating income (loss)0*(18)(16)(16)(22)*(27)(17)(10)(15)*(11)013
Interest expense1*0000*0002*222
Income tax expense (benefit)2*(2)132*52(4)9*322
Net income (loss)(2)*(15)(16)(18)(21)*(31)(17)(4)(22)*(12)(0)12
Earnings per share, basic USD per share(0.04)*(0.31)(0.34)(0.39)(0.46)*(0.66)(0.36)(0.09)(0.48)*(0.26)0.000.26
Earnings per share, diluted USD per share(0.04)*(0.31)(0.34)(0.39)(0.46)*(0.66)(0.36)(0.09)(0.48)*(0.26)0.000.22
Weighted average shares, basic millions of shares47*47474747*47474747*474747
Weighted average shares, diluted millions of shares48*47474747*47474747*474754

Balance sheet

CSV

Fiscal quarters (COHU's year ends in late December)

In millions of dollarsDec 30, 2023Mar 30, 2024Jun 29, 2024Sep 28, 2024Dec 28, 2024Mar 29, 2025Jun 28, 2025Sep 27, 2025Dec 27, 2025Mar 28, 2026Jun 27, 2026Sep 26, 2026
Cash and cash equivalents246191203189206152164150227211220272
Short-term investments9080598056494548257278279236
Inventory156152146144142139138134129131140149
Total current assets639573546542534479491514750754789836
Property and equipment, net697675777576777777777575
Right-of-use asset171615141413323129282827
Goodwill242238237243235273283282283280279279
Total assets1,1501,0741,0391,0329999761,0101,0211,2431,2351,2581,298
Accounts payable343022233131415141496277
Current portion of long-term debt6323211111111111117
Total current liabilities1039179858592101117109117137162
Long-term debt348887777285285285285
Lease liability, non-current13131110109323232313130
Retained earnings319304288270249218201197174162162174
Total stockholders' equity950915896885857828831831786769775791
Total liabilities and equity1,1501,0741,0391,0329999761,0101,0211,2431,2351,2581,298
Common shares outstanding (cover page) millions of shares474747474747474747474747

Cash flows

CSV

Fiscal quarters (COHU's year ends in late December)

In millions of dollarsDec 30, 2023Mar 30, 2024Jun 29, 2024Sep 28, 2024Dec 28, 2024Mar 29, 2025Jun 28, 2025Sep 27, 2025Dec 27, 2025Mar 28, 2026Jun 27, 2026Sep 26, 2026
Net income (loss)(2)*(15)(16)(18)(21)*(31)(17)(4)(22)*(12)(0)12
Stock-based compensation5*56*5*5*66*6*5*67*5*
Depreciation and amortization13*1313*13*13*1313*14*11*1010*10*
Net cash from operating activities3*(14)1*17*(2)*(10)16*(14)*year only1010*6*
Purchases of property and equipment4*32*2*3*113*4*3*22*3*
Net cash from investing activities(42)*719*(22)*18*(34)(1)*(13)*(210)*(22)(1)*41*
Proceeds from issuing common stockyear only———————————
Share repurchases13*118*8*0*80*(0)*0*00*0*
Repayments of long-term debt1*301*0*1*00*0*1*00*0*
Net cash from financing activities(12)*(44)(7)*(8)*1*(2)1*(0)*248*(5)1*5*
Net change in cash(48)*(54)12*(14)*17*(55)13*(14)*77*(16)9*53*

Compare with peers

SIC 3825 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3825 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
CompanyCash ($M)Revenue, quarter ($M)Operating cash flow, quarter ($M)Shares outstandingRunwayQuarter
Cohu2721735.6*47.3M— 10-QSep 26, 2026
Aehr Test Systems11619*1.8*32.6M— 10-KMay 29, 2026
Transcat5.89710*9.4M— 10-QSep 26, 2026
EyePoint1100.5(62)*86.2M2.9 quarters 10-QJun 30, 2026
10x Genomics50315117*not reported— 10-QJun 30, 2026
Allient4215414*17.0M— 10-QJun 30, 2026
Onto Innovation1,25334362*49.1M— 10-QJun 30, 2026
Cytek Biosciences74481.4*130.0M— 10-QJun 30, 2026
Senseonics Holdings4514(30)*52.9M4.7 quarters 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.